Adrian Ortiz is the Executive Director of Process Research and Development at Eli Lilly, a position they have held since 2025. Prior to this, Adrian worked as a Principal Scientist at Amgen from 2019 to 2021 and at Bristol-Myers Squibb from 2010 to 2019, contributing to process chemistry research and development. Adrian earned a Doctor of Philosophy in Organic Chemistry from The Scripps Research Institute, following dual Bachelor’s degrees in Chemistry and Physiological Sciences from the University of Arizona.
This person is not in the org chart
This person is not in any teams
This person is not in any offices